NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027

Market By Systems, Application, And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to the research by Triton, the North America neurostimulation device market is expected to grow significantly in terms of revenue at a CAGR of 9.95% for the forecasting years 2019-2027.

Countries that have been covered in the neurostimulation device market in North America are:

•           The United States

•           Canada

North America is expected to be the largest market in terms of revenue during the forecasted period. The increased use of neurostimulation devices for treating various diseases such as chronic pain, Parkinson’s disease, epilepsy, and depression has been driving the market growth. In the US, the availability of reimbursement by Medicare boosting the adoption of neurostimulation devices. Along with that, neurostimulation device manufacturing companies are developing innovative products to expand their portfolio and increase the market share of the country.

Report scope can be customized per your requirements. Request For Customization

Moreover, the rapid growth in the population of older people in the US has resulted in the adoption of neurostimulation devices. For instance, according to the Alzheimer’s Association, the number of individuals aged 65 and above suffering from Alzheimer’s disease is predicted to reach around 14 million. This would create massive growth opportunities for the growth of the neurostimulation device market. Furthermore, significant investments made by the government in research & development activities are fueling the neurostimulation device market in the US. The country is estimated to hold the largest market share in the North American region over the forecasted period.

Neuronetics Inc. is a leading medical device company that develops non-invasive therapies for neurological and psychiatric disorders. The company provides the NeuroStar TMS Therapy system, which is used to treat patients suffering from a depressive disorder. The company also offers services such as clinical training, practice support, patient education, and reimbursement support. Neuronetics was founded in 2003 and headquartered in Pennsylvania.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    NORTH AMERICA NEUROSTIMULATION DEVICE MARKET – SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTES

2.2.3.   BARGAINING POWER OF SUPPLIERS

2.2.4.   BARGAINING POWER OF BUYERS

2.2.5.   THREAT OF RIVALRY

2.3. VALUE CHAIN OUTLOOK

2.4. MARKET TRENDS

2.5. MARKET SHARE OUTLOOK

2.6. PESTLE OUTLOOK

2.7. MARKET ATTRACTIVENESS INDEX

2.8. KEY INSIGHT

2.9. MARKET DRIVERS

2.9.1.   RISING INCIDENCE OF NEURO DISEASES

2.9.2.   INCREASING GERIATRIC POPULATION

2.9.3.   GROWING DEMAND FOR MRI SCANS

2.9.4.   FAVORABLE REIMBURSEMENT POLICIES

2.10.            MARKET RESTRAINTS

2.10.1.                HIGH COST OF NEUROMODULATION TREATMENT

2.10.2.                PRESENCE OF ALTERNATIVE THERAPY

2.11.            MARKET OPPORTUNITIES

2.11.1.                HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION

2.11.2.                TECHNOLOGICAL DEVELOPMENT

2.11.3.                GROWING INCIDENCE OF CHRONIC DISCOMFORT

2.12.            MARKET CHALLENGES

2.12.1.                STRINGENT REGULATORY APPROVALS

2.12.2.                SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION DEVICES

3.    NEUROSTIMULATION DEVICE MARKET OUTLOOK – BY SYSTEM

3.1. SPINAL CORD STIMULATORS (SCS)

3.2. DEEP BRAIN STIMULATORS (DBS)

3.3. SACRAL NERVE STIMULATORS (SNS)

3.4. VAGUS NERVE STIMULATORS (VNS)

3.5. GASTRIC ELECTRIC STIMULATOR

3.6. OTHER SYSTEMS

4.    NEUROSTIMULATION DEVICE MARKET OUTLOOK – BY APPLICATIONS

4.1. PAIN MANAGEMENT

4.2. EPILEPSY

4.3. ESSENTIAL TREMOR

4.4. URINARY AND FECAL INCONTINENCE

4.5. DEPRESSION

4.6. DYSTONIA

4.7. GASTROPARESIS

4.8. PARKINSON’S DISEASE

4.9. OTHER APPLICATIONS

5.    NEUROSTIMULATION DEVICE MARKET – REGIONAL OUTLOOK

5.1.1.   COUNTRY ANALYSIS

5.1.1.1.      THE UNITED STATES

5.1.1.2.      CANADA

6.    COMPANY PROFILES

6.1. NEURONETICS, INC.

6.2. ST. JUDE MEDICAL, INC. (ACQUIRED BY ABBOTT LABORATORIES)

6.3. HOCOMA AG

6.4. NEVRO CORP.

6.5. CYBERONICS INC.

6.6. COGENTIX MEDICAL, INC.

6.7. DEPUY SYNTHES COMPANIES

6.8. DR. LANGER MEDICAL GMBH

6.9. MEDTRONIC PLC

6.10.            THE MAGSTIM COMPANY LIMITED

6.11.            ECTRON LIMITED

6.12.            BOSTON SCIENTIFIC CORPORATION

6.13.            EKSO BIONICS HOLDING INC.

6.14.            ALEVA NEUROTHERAPEUTICS SA

6.15.            HELIUS MEDICAL TECHNOLOGIES

7.    RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.1.1.   OBJECTIVES OF STUDY

7.1.2.   SCOPE OF STUDY

7.2. SOURCES OF DATA

7.2.1.   PRIMARY DATA SOURCES

7.2.2.   SECONDARY DATA SOURCES

7.3. RESEARCH METHODOLOGY

7.3.1.   EVALUATION OF PROPOSED MARKET

7.3.2.   IDENTIFICATION OF DATA SOURCES

7.3.3.   ASSESSMENT OF MARKET DETERMINANTS

7.3.4.   DATA COLLECTION

7.3.5.   DATA VALIDATION & ANALYSIS

            

List of table

TABLE 1        NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

TABLE 2        NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 3        NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 4        CONDITION TREATED BY NEUROSTIMULATION DEVICES IN THE UNITED STATES

TABLE 5        NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 2      VALUE CHAIN OUTLOOK

FIGURE 3      NEUROSTIMULATION DEVICE COMPANY MARKET SHARE OUTLOOK 2018 (%)

FIGURE 4      NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)

FIGURE 5      NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)

FIGURE 6      NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE 7      NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE 8      NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)

FIGURE 9      NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)

FIGURE 10   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)

FIGURE 11   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY EPILEPSY 2019-2027 ($ MILLION)

FIGURE 12   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)

FIGURE 13   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)

FIGURE 14   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)

FIGURE 15   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DYSTONIA 2019-2027 ($ MILLION)

FIGURE 16   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)

FIGURE 17   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)

FIGURE 18   NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 19   THE UNITED STATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 20   CANADA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

            

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;